Korean J Anesthesiol.  1999 Nov;37(5):938-942. 10.4097/kjae.1999.37.5.938.

Malignant Hyperthermia during General Anesthesia and Anesthetic Management for That Same Patient in Day Surgery Center: A case report

Affiliations
  • 1Department of Anesthesiology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea.

Abstract

Malignant hyperthermia is a potentially fatal hypermetabolic syndrome characterized by hyperpyrexia and skeletal muscle rigidity. We experienced a case of malignant hyperthermia after general anesthesia with halothane and succinylcholine in day surgery center. 2 years old male patient arrived to get congenital ptosis operation. He was relatively healthy and had no considerable past or family history of hereditary disease. Anesthesia induced with halothane inhalation and succinylcholine. After induction, he abruptly showed masseter muscle rigidity, total body rigidity, elevation of end-tidal CO2 tension, tachycardia and hyperthermia. Under the suspicion of malignant hyperthermia, all anesthetics were discontinued and vigorous emergency treatment was attemped with dantrolene sodium. The patient survived without any sequele and discharged after 11 days. About 10 months later, that same patient comes to our hospital to take the operation. We experienced successful anesthetic management for malignant hyperthermia.

Keyword

Hyperthermia, malignant; Muscle, masseter rigidity; Pharmacology, dantrolene sodium

MeSH Terms

Ambulatory Surgical Procedures*
Anesthesia
Anesthesia, General*
Anesthetics
Child, Preschool
Dantrolene
Emergency Treatment
Fever
Genetic Diseases, Inborn
Halothane
Humans
Inhalation
Male
Malignant Hyperthermia*
Masseter Muscle
Muscle, Skeletal
Succinylcholine
Tachycardia
Anesthetics
Dantrolene
Halothane
Succinylcholine
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error